In recent years, regenerative medicine has emerged as a new pharmaceutical field.
Almost of the regenerative medicine products use living cells as the main substance, which is completely different from already-existing medicines.
We dare to stand on the conviction that the emerging regenerative medicine is not distinct from conventional ones, but rather can incorporate those to reach at next stage.
This approach meets to an old saying , “温故知新” , an oriental historical allusion that “visiting old, learn new”.
In order to accomplish 100-year of healthy lives to all, we are seeking to establish new concept of regenerative medicine product, hAP (holding Active Pharmaceutical ingredient) cell as combination of conventional pharmaceutical and living cell